A drug administered to a patient for treatment, listed in
SEER*Rx as a chemotherapeutic,
hormonal or immunotherapy agent should be coded under chemotherapy [#1390],
hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s)
listed in SEER*Rx for that agent. Do not code under the data item,
Other Therapy [NAACCR #1420]. Refer to the
2026 SEER manual
for more information.
|
tgDCC-E1A
|
Biologic therapy (BRM, immunotherapy)
|
Head & neck,
ovarian cancer
|
Yes
|
|
sibrotuzumab
|
Chemotherapy
|
Breast,
colorectal,
lung,
other cancer,
pancreatic
|
Yes
|
|
sT4
|
AIDS drug
|
|
No
|
|
rgp120/HIV-1 (IIIB)
|
AIDS drug
|
|
No
|
|
rgp120 CHO
|
AIDS drug
|
|
No
|
|
recMAGE-A3+AS15
|
Biologic therapy (BRM, immunotherapy)
|
Melanoma,
NSCLC
|
Yes
|
|
radiotherapy
|
Radiation
|
|
Yes
|
|
rV-MART-1
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rV-GP100
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rF-gp100
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rF-Tyrosine Vaccine
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rF-Mgp100
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rF-MART-1
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
rCD4
|
AIDS drug
|
|
No
|
|
pivaloyloxymethylbutyrate
|
Chemotherapy
|
Liver,
lung cancer
|
Yes
|
|
p53 Tumor Suppressor Gene
|
Biologic therapy (BRM, immunotherapy)
|
Head & neck,
liver,
ovarian cancer
|
Yes
|
|
hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482
|
Chemotherapy
|
Kidney
|
Yes
|
|
hR3
|
Biologic therapy (BRM, immunotherapy)
|
Head & neck cancer
|
Yes
|
|
hIL13-PE38QQR (ligand targeted toxin)
|
Chemotherapy
|
Kidney cancer
|
Yes
|
|
gp100 Plasmid Vector in Gold Particles
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
gp100 Peptide Vaccine
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
gp100 DNA Vaccine
|
Biologic therapy (BRM, immunotherapy)
|
Skin cancer
|
Yes
|
|
diazooxonorleucine
|
Chemotherapy
|
Skin cancer
|
Yes
|
|
dabrafenib
|
Chemotherapy
|
Melanoma,
Lung,
Thyroid
|
Yes
|
|
cAC10-vcMMAE(4)
|
Chemotherapy
|
Hodgkin lymphoma
|
Yes
|